Skip to main content

Table 3 Differences in cumulative survival rates among the 31 N(−) CRC patients according to the current survival status and the cutoff number of TDLNs (NDLNs) of 15

From: A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection

Part I

Current survival status

 
 

Dead (n = 3)

Alive (n = 28)

p value

No. of TDLNs (=NDLNs) (mean ± SD)

13.0 ± 12.3

20.7 ± 11.5

0.181*

Follow-up periods (mean ± SD)(month)

57.1 ± 59.7

89.8 ± 33.9

0.316*

Cumulative survival rate (%)

 1 year

67.7%

100.0%

 

 2 years

67.7%

100.0%

 

 5 years

33.3%

100.0%

 

 10 years

33.3%

100.0%

 

 12 years

0.0%

100.0%

 

Part II

TDLNs (=NDLNs)

 
 

≤ 15 (n = 14)

> 15 (n = 17)

p value

No. of deaths (n = 3)

2

1

0.431**

Follow-up periods (mean ± SD) (month)

87.5 ± 41.4

86.0 ± 43.2

0.912*

Survivals (mean, 95%CI) (month)

117.0 (99.3–134.7)

131.6 (120.4–142.8)

0.529***

Cumulative survival rate (%)

   

 1 year

92.3%

100.0%

 

 2 years

92.3%

93.8%

 

 5 years

92.3%

93.8%

 

 10 years

92.3%

93.8%

 

 12 years

61.5%

93.8%

 
  1. CRC colorectal cancer, No. number, TDLNs total dissected lymph nodes, NDLNs negative dissected lymph nodes, SD standard deviation, CI confidence interval
  2. *Student’s t test/Mann–Whitey U test
  3. **Chi-square test
  4. ***Log-rank